Pyrotinib plus capecitabine for trastuzumab-resistant, HER2-positive advanced breast cancer (PICTURE): a single-arm, multicenter phase 2 trial. - Cao, Jun; Teng, Yuee; Li, Huiping; Zhang, Lili; Ouyang, Quchang; Xie, Weimin; Pan, Yueyin; Song, Zhenchuan; Ling, Xiaoling; Wu, Xiaohong; Xu, Jingwei; Li, Li; et al. (BMC Medicine, 2023)